Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NT5E | P21589 | 1/20 | 0.65 |
| ▸ | HPRT1 | P00492 | 1/20 | 0.59 |
| ▸ | TGM2 | P21980 | 1/20 | 0.58 |
| ▸ | HINT1 | P49773 | 4/20 | 0.55 |
| ▸ | KRAS | P01116 | 10/20 | 0.53 |
| ▸ | GSK3A | P49840 | 2/20 | 0.52 |
| ▸ | RPS6KA3 | P51812 | 2/20 | 0.52 |
| ▸ | MAPK14 | Q16539 | 2/20 | 0.52 |
| ▸ | FUT5 | Q11128 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21057089 | 0.91 | NT5E (0.61) | NT5EHPRT1TGM2HINT1KRAS | |
| SCHEMBL12300464 | 0.91 | NT5E (0.58) | NT5EHPRT1TGM2HINT1KRAS | |
| SCHEMBL12300460 | 0.89 | NT5E (0.59) | NT5EHPRT1TGM2HINT1KRAS | |
| SCHEMBL12300422 | 0.89 | NT5E (0.56) | NT5EHPRT1TGM2HINT1KRAS | |
| SCHEMBL18841403 | 0.86 | NT5E (0.64) | NT5ETGM2HINT1KRASGSK3A | |
| SCHEMBL21128140 | 0.85 | NT5E (0.57) | NT5EHPRT1TGM2HINT1KRAS | |
| SCHEMBL21128395 | 0.85 | NT5E (0.57) | NT5EHPRT1TGM2HINT1KRAS | |
| SCHEMBL8883219 | 0.83 | POLB (0.61) | NT5EHPRT1TGM2 | |
| SCHEMBL12300425 | 0.83 | HPRT1 (0.55) | NT5EHPRT1TGM2HINT1KRAS | |
| SCHEMBL12154664 | 0.82 | HPRT1 (0.61) | NT5EHPRT1TGM2HINT1KRAS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0398231-B1 | Nucleoside analogs | ACAD OF SCIENCE CZECH REPUBLIC (CZ) | 1997-07-16 | — | — | EP | disclosed |